V-ZOLINE

Land: Israel

Sprog: engelsk

Kilde: Ministry of Health

Aktiv bestanddel:

TETRAHYDROZOLINE HYDROCHLORIDE

Tilgængelig fra:

VITAMED PHARMACEUTICAL INDUSTRIES LTD

ATC-kode:

S01GA02

Lægemiddelform:

DROPS

Sammensætning:

TETRAHYDROZOLINE HYDROCHLORIDE 0.05 %W/V

Indgivelsesvej:

OCULAR

Recept type:

Not required

Fremstillet af:

VITAMED PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Terapeutisk gruppe:

TETRYZOLINE

Terapeutisk område:

TETRYZOLINE

Terapeutiske indikationer:

relief from soreness, burning, itching, irritation redness due to congestion of the eyes.

Autorisation dato:

2020-12-31

Indlægsseddel

Patient package insert according to
Pharmacists' Regulations (Preparations)- 1986
This medicine can be sold without a physician’s prescription
V-ZOLINE, Eye Drops
Composition:
Tetrahydrozoline Hydrochloride 0.05% W/V.
Each 1 ml contains: 0.5 mg Tetrahydrozoline Hydrochloride.
Inactive ingredients and allergens in the medicine- see section 6
“Additional information” and in section 2 "Important information
about some of
the ingredients of this medicine".
Read the entire leaflet carefully before using this medicine.
This leaflet contains concise information about the medicine. If you
have any
further questions, refer to the doctor or pharmacist.
Use this medicine according to the instructions in section 3 "How to
use this medicine?" in this leaflet. Consult the pharmacist if you
need
additional information. Refer to a doctor if the symptoms of your
illness get worse or if they do not improve after 3 days.
1. What is the medicine intended for?
The medicine is intended for relief from soreness, burning, itching,
irritation and redness due to congestion of the eyes.
Therapeutic group: Sympathomimetic decongestants.
2. Before using this medicine
Do not use this medicine if:
Special warnings regarding the use of this medicine
• Before using the medicine, tell the doctor if you are suffering
from an infection, the presence of a foreign body and mechanical or
chemical
injury of the eye.
• Use the medicine only for mild irritation of the eyes.
• Use of the medicine is not recommended in complex conditions of
the eye, such as glaucoma.
• Avoid contact of the medicine with the skin in cases of
inflammation or injury, due to the presence of Boric Acid among the
medicine’s
ingredients.
• Discontinue use and refer to a doctor if the signs of the illness
(symptoms) do not improve within 3 days, or if the discomfort and
redness
intensify or persist, or in the event of eye pain, or if visual
disturbances occur.
• Use of the medicine may cause temporary dilation of the pupil.
• Prolonged use and abuse of the me